Univest Financial’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.7M Buy
6,590
+126
+2% +$80.8K 0.21% 83
2025
Q4
$4.37M Sell
6,464
-416
-6% -$283K 0.23% 75
2025
Q3
$4.4M Sell
6,880
-4,666
-40% -$2.83M 0.25% 73
2025
Q2
$6.19M Buy
11,546
+3,030
+36% +$1.45M 0.37% 57
2025
Q1
$3.58M Buy
8,516
+6,193
+267% +$2.69M 0.23% 79
2024
Q4
$960K Sell
2,323
-125
-5% -$54.8K 0.06% 159
2024
Q3
$1.24M Buy
+2,448
New +$1.19M 0.08% 138

Other funds holding IDXX

Univest Financial's IDXX Position: Q1 2026 in Review

Univest Financial increased its Idexx Laboratories (IDXX) stake by 1.9% in Q1 2026, buying an estimated $80.8K and bringing the position to 6,590 shares worth $3.7M. The position accounts for 0.21% of the portfolio, ranked #83.

Univest Financial first reported a position in IDXX in Q3 2024 and has held it in 7 quarters since. The position peaked at $6.19M in Q2 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Univest Financial held 6,590 shares of Idexx Laboratories worth $3.7M as of Q1 2026.
  • Univest Financial bought 126 Idexx Laboratories shares in Q1 2026, an estimated $80.8K.
  • Idexx Laboratories made up 0.21% of Univest Financial's portfolio in Q1 2026, its #83 holding.
  • Univest Financial first reported a position in Idexx Laboratories in Q3 2024 and has held it in 7 quarters since.
  • Univest Financial's Idexx Laboratories position peaked at $6.19M in Q2 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Univest Financial's 13F filing for Q1 2026, filed 1 May 2026.